www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Human Herpesvirus-6

 

 

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Tables and Figures

Table 1: Susceptibility of HHV-6A to Inhibition by Currently Available Antiviral Compounds

Table 2: Susceptibility of HHV-6B to Inhibition by Antiviral Agents

 

Vignettes

Berger S.  Emergence of Infectious Diseases into the 21st Century, 2008.

Potenza et al.HHV-6A in Syncytial Giant-Cell Hepatitis. N Engl J Med. 2008 Aug 7;359(6):593-602.

Review Article:  Sun HY, et al.  Pharmacotherapy of post-transplant viral infections.  Expert Opin Pharmacother 2008;9(14):2409-2421.

Review Article:  Funk GA, et al. Viral dynamics in transplant patients: implications for disease. Lancet Infectious Diseases 2007;7:460-472.

 

Authors

 

Nina Singh, M.D., Donald R. Carrigan, Ph.D.

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]